Home
>
National Drug Code (NDC)
>
Accupril
Accupril - 0071-0532-23 - (QUINAPRIL HYDROCHLORIDE)
Drug Information of Accupril
| Product NDC: | 0071-0532 |
| Proprietary Name: | Accupril |
| Non Proprietary Name: | QUINAPRIL HYDROCHLORIDE |
| Active Ingredient(s): | 20 mg/1 & nbsp; QUINAPRIL HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Accupril
| Product NDC: | 0071-0532 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019885 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19911119 |
Package Information of Accupril
| Package NDC: | 0071-0532-23 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0532-23) |
NDC Information of Accupril
| NDC Code | 0071-0532-23 |
| Proprietary Name | Accupril |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0532-23) |
| Product NDC | 0071-0532 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | QUINAPRIL HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19911119 |
| Marketing Category Name | NDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | QUINAPRIL HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
